Objectives: Controversy still surrounds the use of extracorporeal life support (ECLS) in patients with single ventricle physiology. An analysis of the experience with a group of neonates who underwent stage I Norwood palliation and received ECLS is reported. Methods: A retrospective review of hospital records, operative notes and perfusion data was performed in a group of 12 consecutive patients undergoing ECLS in the perioperative period after stage I. An analysis to identify risk factors for poor outcome was performed. Results: The mean age and weight were 3.9 days (1±14) and 2.6 kg (1.4±3.8), respectively. There were 3/12 patients under 2.5 kg and four patients were under 35 weeks of gestation. The most common diagnosis (7/12) was hypoplastic left heart syndrome with aortic atresia. Associated extracardiac anomalies were present in four patients. Three patients had an additional cardiac defect and two of these required an additional surgical procedure besides the stage I Norwood. The mean circulatory arrest was 56 min (46±63). ECLS was initiated preoperatively in one, intraoperatively in nine, and postoperatively in two patients. The indication for support was: arrhythmia (one), low output (six), cardiac arrest (three), unbalanced circulation (one), and hypoxemia (two). The mean duration of support was 68 h (24±192). Eight patients were weaned off support, and six were discharged home in good condition. Morbidity included sepsis in ®ve, renal failure in ®ve, neurologic sequelae in three, and bleeding in two. Prematurity, renal dysfunction and the initiation of ECLS outside the operating room were signi®cantly associated with poor outcome. Residual hemodynamic effect, low birth weight and neurologic event showed a tendency towards poor outcome, but did not reach statistical signi®cance. Conclusions: Although the use of ECLS in patients with single ventricle physiology still carries a signi®cant risk, prompt initiation of support can improve the outcome in a group of patients with impaired cardiopulmonary function after stage I palliation. q
Introduction
Extracorporeal membrane oxygenation (ECMO) has emerged as an effective technique for the mechanical support of many patients with refractory cardiac dysfunction following surgical repair of their congenital heart defect. After considerable experience with this technique in various centers, the reported success rate for hospital survival of patients who were on ECMO approximates 40% [1±8] . Patients with a single ventricle physiology constitute a particularly challenging subgroup of patients, with a reportedly worse overall outcome. The lower survival rate in these patients has been, in part, attributed to an imbalance between systemic and pulmonary perfusion, and its associated impact on coronary perfusion due to the diastolic run-off into the pulmonary bed. In addition, because the initial stage of this palliation requires an arterial communication, some degree of volume overload to the single pumping ventricle occurs. These features further complicate the recovery of a dysfunctional myocardium when weaning from cardiopulmonary bypass (CPB) and may explain why patients with a single ventricle type physiology, have a worse overall outcome.
Due to the limited experience with extracorporeal support and the poorer overall outcome with this particular patient population, single ventricle physiology has been considered a relative contraindication for post-cardiotomy supportsurgical palliation between January 1998 and September 1999 was performed. This review included hospital records, operative notes, as well as anesthesia and perfusion data. Multiple clinical variables were analyzed for their impact on survival to hospital discharge. These clinical variables included demographic factors, certain aspects of CPB, and details regarding the management of the extracorporeal support and its complications (Appendix A) .
The decision to initiate extracorporeal support was based on the presence of low cardiac output, persistent acidosis, dif®culty to balance pulmonary/systemic circulation (Qp/ Qs), severe hypoxemia, the presence of arrhythmia, and/or cardiac arrest in the perioperative period. We did not use a speci®c algorithm or clinical pathway to dictate when extracorporeal support would be employed. Our practice was to employ intravenous (dopamine and sodium nitroprusside) and/or inhalational (CO 2 /N 2 ) therapies to either redistribute or improve the cardiac output. When these maneuvers were insuf®cient, then extracorporeal support was provided to the patient. All patients are represented in Table 1 . Normal a HLHS, hypolplastic left heart syndromw; AS, aortic stenosis; mh, mitral hypoplasia; aa, aortic atresia; ma, mitral atresia; dorv, double outlet right ventricle; wks, weeks; cor triatria, cor triatriatum; tapvc. total anomalous pulmonary venous connection; cdh, congential diphragmatic hernia; lco, low cardiac output; unbal qp/qs, unbalanced pulmonary/systemic circulation; pod, postoperative day; svt, supraventricular tachycardia.
ECMO circuit

Circuit components
The CPB circuit consisted of a 0.25-inch PVC tubing and a Carmeda-coated Minimax Plus oxygenator/heat exchanger (Medtronic Cardiopulmonary, Inc., Anaheim, CA), an open Micro venous/cardiotomy reservoir (Cobe Laboratories, Arvada, CO), and roller pumps (Sarns/3M Healthcare, Ann Arbor, MI). The system was con®gured to allow full CPB in the operating room with the option to provide postoperative ECMO or ventricular assist (VAD) without the interruption of blood¯ow or gas exchange when adjusting the level of support, thus eliminating exposure of the perfusate to new surfaces or interrupting the support.
Priming components
The priming volume is approximately 450 cc, consisting of Plasma-lyte A which is displaced by fresh whole blood (approximately 24±48-h-old) to achieve a pump hematocrit of 20%. Additional medications include heparin (100 units/ kg), solumedrol (30 mg/kg), lasix (1 mg/kg), mannitol (0.5 g/kg), NaHCO 3 (10 mEq), oxacillin (25 mg/kg), and gentamycin (2.5 mg/kg). In addition, 100 units/kg of heparin are administered to the patient just prior to cannulation. Fig. 1 illustrates the pathway for blood during conventional CPB in the operating room. From the venous cannulation, blood drains by gravity to the venous reservoir, then is pumped by the arterial roller pump to the integrated heat exchanger and oxygenator which has ports for laboratory sampling and volume administration. From the oxygenator, blood travels to the arterial cannula; this line includes an arterial to venous bridge which allows recirculation of the A±V loop. This bridge is con®gured with straight 0.25-inch tubing connectors with luer adapters, stopcocks and 0.25-inch perfusion adapters. This allows the bridge to remain closed to the A±V loop and crystalloid primed until needed, negating the need to`¯ash' the bridge routinely. When ECMO is needed following surgical repair, the venous reservoir is removed from the circuit by utilizing the reservoir bypass loop which facilitates the smooth transition from CPB to ECMO (Fig. 2) . Fig. 3 illustrates the blood path during ECMO, this includes a 4-inch VAD line that is clamped and crystalloid primed for conversion to VAD, if desired. An additional 6-foot line is clamped and crystalloid primed to provide a closed loop to recirculate the bypassed oxygenator during the VAD. Fig. 4 illustrates the circuit con®guration during VAD, by moving the clamp positions; conversion from ECMO to VAD is achieved without interruption of support.
Perfusate pathway
Anticoagulation
A continuous heparin sodium infusion was used in order to maintain an activated clotting time of 180±200 s. Hemoglobin was maintained at 10 mg/dl during full support, and greater than 14 mg/dl when partial support was used or when weaning from the circuit was anticipated. Fresh whole blood was used during surgery and in the immediate postoperative period in order to achieve hemostasis. Subsequently, packed red blood cells were used to increase the hematocrit as needed. All blood was tested for human immunode®ciency virus and hepatitis C.
Cannulation
All patients received cannulation via median sternotomy using a single right atrial cannula and an arterial cannula in the main pulmonary artery or reconstructed neo aorta. No left atrial cannula was placed for additional drainage if there was an unobstructed intra-atrial communication. In the case of intraoperative institution of support, the patient was kept on the same circuit used for the surgery. The cannulae were kept in place, the pursestrings were controlled with a tourniquet and surgical clips, the chest was closed with a silastic patch, and a direct wall suction catheter was used to evacuate shed mediastinal blood. Adequate cardiac decompression was evaluated by direct inspection and/or echocardiogram. If the patient left the operating room without support, but was considered likely to require it in the immediate postoperative period, then the pursestrings and tourniquets were secured with a surgical clip and left in the chest. This action would facilitate rapid recannulation and the institution of extracorporeal support when needed.
Flows
The primary goal of the extracorporeal support in this patient population with their parallel circulations was to maintain adequate tissue perfusion, minimize pulmonary overcirculation, and provide time for the myocardial and/ or lung dysfunction to recover. The¯ows (which ranged between 50 and 150 ml/kg per min) were titrated according to each patient's needs, maintaining adequate gas exchange, tissue perfusion and acceptable acid base status. Accordingly, the mechanical ventilatory support and the gas¯ow through the oxygenator were adjusted to achieve acceptable levels of alveolar gas exchange. While on extracorporeal support, all inotropic medications were discontinued.
Ventilator
After the initiation of the circulatory support, manipulations in the inspired gas mixture on the ventilator were made to achieve acceptable arterial blood gases. The mechanical ventilatory support was titrated according to the amount of extracorporeal support. If the baby was on greater than 75 cc/kg¯ow per min, the ventilator would typically be set to provide a 20 cc/kg tidal volume at ten breaths/min with an attendant end expiratory pressure of 10 cm of H 2 O. The patients received a remifentanil infusion for sedation.
Shunt management
The prevailing strategy during this experience was to leave the aorta±pulmonary shunt open during the period of support, unless there was a signi®cant degree of run-off towards the pulmonary circuit. If there was a signi®cant fall in the mean arterial pressure (particularly diastolic pressure) and/or signi®cant cardiac distention, the shunt was partially occluded until hemodynamic recovery occurred, at which point the shunt was reopened. The size of the shunt was 4.0 mm, unless the baby was prematurely born, in which case, the shunt was 3.5 mm in size.
Fluid management
Depending on their¯uid status and renal function, these patients were managed with¯uid restriction, diuretics and/ or ultra®ltration in an effort to decrease interstitial edema and improve cardiopulmonary function. Electrolytes were kept within the normal range and nutritional support was provided.
Weaning
Once signs of cardiopulmonary recovery were evident as judged by improved hemodynamic parameters, an increase in arterial override, improved cardiac contractility by direct inspection, a well balanced Qp/Qs, and adequate alveolar gas exchange, the extracorporeal support was lowered. The ventilator support was increased and inspired carbon dioxide, low dose dopamine and sodium nitroprusside may have been administered in order to achieve a balance in systemic and pulmonary circulations. This process was monitored by frequent clinical observation and arterial blood gas analysis. Delayed sternal closure was usually performed 24 h after decannulation.
Statistical analysis
Data analysis was performed using SPSS (SPSS, Inc., Chicago, IL). The cross-tabulation procedure and Fisher's exact test were used for all the discrete variables. The continuous variables were analyzed with a Mann±Whitney test. Statistical signi®cance was determined at P , 0:05.
Results
The mean age in this group of patients was 3.9 days, with a range of 1±14 days. The mean weight was 2.6 kg, with a range of 1.4±3.8 kg. There were 13 runs of extracorporeal support in 12 patients. The mean duration was 67 h, with a median of 48 and a range of 24±192 h. After the support, 8/ 12 patients were successfully weaned off the support and 6/ 12 were discharged home.
There were three patients with a weight of 2 kg or less. Four patients had gestational ages of less than 35 weeks at birth, and two of these patients were products of multiple pregnancy (twins and triplets, respectively). Another patient in this group had a diagnosis of congenital diaphragmatic hernia, hypoplastic left lung and scimitar syndrome, in addition to hypoplastic left heart syndrome. This patient underwent stage I Norwood palliation 3 days after his diaphragmatic hernia repair.
The most common cardiac diagnosis was hypoplastic left heart syndrome of the mitral atresia, aortic atresia variant. One patient with critical aortic stenosis underwent a failed balloon valvuloplasty and had stage I Norwood 2 days later. Another patient had a prenatal diagnosis of severely dilated and poorly functioning left ventricle, associated with mitral valve hypoplasia and mitral regurgitation. The aortic arch was unobstructed but there was retrograde¯ow via the ductus into the arch. This baby had a stage I palliation at 5 days of age [9] .
Other associated cardiac anomalies were present in ®ve patients and included cor triatriatum, dilated myopathy, scimitar syndrome and partial and total anomalous pulmonary venous connection. Additional surgical procedures were performed in two of these patients: a partial ventriculectomy and the repair of total anomalous pulmonary venous drainage, respectively.
Associated non-cardiac diagnoses included: Turner syndrome in one patient, chromosome 11 deletion in another patient, renal dysplasia in a third, and a congenital diaphragmatic hernia as well as scimitar syndrome in the fourth patient.
The mean duration of deep hypothermic circulatory arrest was 56 min, with a range between 46 and 63 min. A comparison of the pre-support variables is shown in Table 2 .
The most common indication for support was myocardial dysfunction, followed by cardiac arrest, inability to balance Qp/Qs, pulmonary dysfunction and arrhythmia. The institution of support was most commonly performed at the conclusion of the surgical repair (9/12). One patient was placed on support after a cardiac arrest before her stage I, and two other patients were supported after suffering a cardiac arrest in the postoperative period.
All of the patients who were hospital survivors had initiation of support in the operating room. Subsequently, ®ve of these patients are known to have completed their second stage (hemifontan or bi-directional Glenn). Unfortunately, one of them died at home after his second stage.
There were no hospital survivors in the group of patients who underwent institution of extracorporeal support outside the operating room, either in the pre-or postoperative period (Table 3 ). All 12 patients had a systemic to pulmonary shunt dependent pulmonary circulation. The degree of pulmonary overcirculation, the adequacy of systemic and coronary perfusion, and the degree of cardiac distension in¯uenced the shunt management. Eight patients were managed with their shunts open throughout the period of their extracorporeal support. Among these eight patients, six were successfully weaned off support and ®ve became hospital survivors.
Four patients required partial closure or total shunt occlusion at the initiation of the support due to the excessive pulmonary overcirculation and inadequate systemic perfusion pressure despite high¯ows. Only one patient was weaned successfully after 48 h of support, and was eventually discharged from the hospital.
Two patients had a devastating neurological complication and were taken off support. A third patient had no recovery of cardiac function after 5 days on the circuit and was similarly removed from support.
The incidence and comparison of major complications between survivors and non-survivors is shown in Table 4 . Non-survivors were more likely to have sustained renal, neurologic, respiratory and bleeding complications, although renal dysfunction was the only event associated with poor outcome (P , 0:05). All of the neurologic events were present in the non-survivor group, however, this factor did not reach statistical signi®cance. Sepsis was evenly distributed among survivors and non-survivors.
There were no long-term neurologic, renal or pulmonary sequelae in any of the survivors.
Discussion
Currently, extracorporeal membrane oxygenator (ECMO) has become a well established form of cardiac support for children with myocardial dysfunction after surgical repair of congenital heart defects [1±8]. The appropriate selection of pediatric patients for extracorporeal circulatory support continues to be a matter of controversy, especially in conditions associated with single ventricle physiology [6, 7] . The Extracorporeal Life Support Organization's (ELSO) registry uses a mixture of anatomic and physiologic criteria to de®ne eight different subgroups of cardiac patients. Hypoplastic left heart syndrome is listed as having a worse overall outcome when ECMO is used. This is based on the experience of 209 accumulated cases, with an average run-time of 126 h and a reported survival of only 27%. Similarly, when looking at patients having a stage I Norwood procedure, this registry reports a 26% hospital survival rate for a group of 97 patients treated [10] .
Our results demonstrate that in the group of patients who required extracorporeal support after stage I Norwood palliation, 66% (8/12) of them could be successfully weaned from extracorporeal support, and 50% (6/12) were discharged home in good condition. The presence of a residual hemodynamic defect determined a poor outcome in one of our patients. This is consistent with the ECMO literature [5, 6, 8] that states that extracorporeal support cannot overcome the handicap of an inadequate repair. If the patients with residual surgical defects were excluded, then the overall success rate to hospital discharge was improved to over 50% in our series.
These results may be directly related to the indications, timing and threshold for the initiation of extracorporeal support. Contrary to the experience of other centers, where the intraoperative initiation of support was associated with worse outcomes [3, 6, 11] , our experience revealed the opposite. In fact, we had a lack of survivors when patients were placed on extracorporeal support out of the operating room, and a much better outcome in those patients placed on support in the operating room. This experience is similar to that reported by Jaggers et al. [12] , where the early institution of extracorporeal support in the operating room was associated with a better chance of survival to hospital discharge in a cohort of patients, including ten patients with single ventricle. There is little doubt that patients with single ventricle physiology are more vulnerable to myocardial damage and tolerate dysfunction less than other patients who do not have the added demands of balancing two circulations and adapting to an increased volume burden. Therefore, it is not surprising that these patients would require some cardiac support postoperatively. By providing mechanical circulatory support in a timely way, this patient population is afforded time to adjust to the increased demands to its ventricle.
Our strategy of maintaining the shunt open during the extracorporeal support is based on clinical and laboratory evidence that antegrade pulmonary blood¯ow is bene®cial [12, 13] . Of course, it is dif®cult to conclude that leaving a shunt patent during extracorporeal support is the cause of the improved outcome in our patients. Perhaps those patients who were able to have their shunts open had more favorable hemodynamics and that is the explanation for their improved outcome. In fact, those with the worse hemodynamics and the most signi®cant myocardial dysfunction, had low perfusion pressures and signi®cant compromise of their coronary perfusion. In this scenario, closure of the shunt provided temporary improvement of the hemodynamic conditions by increasing the systemic perfusion pressure and coronary blood¯ow, and decreased the amount of pulmonary overcirculation and cardiac distension. Not surprisingly, in our experience, the patients who required shunt occlusion at the institution of extracorporeal support had the worse hemodynamic pro®le and required the highest amount of support. We had only one survivor in the group of patients who had their shunts occluded during their support and this patient had his shunt only temporarily occluded. This patient was eventually weaned off and discharged home. Despite the fact that it appeared that occluding the shunt would be associated with a poor outcome, this variable did not reach statistical signi®-cance as a risk factor for mortality.
Although not used in our particular patient population, the VAD device is another form of circulatory support to be used when only myocardial dysfunction is present. A recent report by Thuys et al. [14] included 12 patients with hypoplastic left heart syndrome who were managed with this form of support. Although their report only had a 25% hospital survival rate (3/12) , it demonstrated the advantages of this form of support: effective reduction in preload and wall stress, decrease in anticoagulation needs, decrease in in¯ammatory effects related to the device and simplicity [14, 15] . This is an attractive modality assuming the lung function and the ability to balance the systemic and pulmonary circulations are adequate.
Despite our reported improvement in survival in this patient population, the morbidity in these patients remains quite high. When looking at different potential risk factors for poor outcome, renal dysfunction was the only factor that reached statistical signi®cance. This is consistent with other reports [5, 12] . Bleeding was not a common problem in our experience as opposed to most series [3, 5, 8, 12] . This ®nding may be related to the use of fresh whole blood in the immediate postoperative period and the use of a heparincoated circuit, which allowed the maintenance of lower activated clotting times. Consequently, the need for mediastinal exploration was infrequent.
Neurologic complications were mostly related to intracranial bleeding, which is not surprising given this younger aged group. Those infants with neurologic complications were also the ones who had their support instituted after having had a cardiac arrest. The presence of neurologic dysfunction showed a tendency towards a poor outcome, but it did not reach statistical signi®cance, perhaps because of a small sample size.
In reviewing our experience, we believe that satisfactory results can be achieved when using ECMO support for patients after stage I Norwood palliation. It is clear that failure to wean from CPB after the procedure is not a contraindication to this therapy, assuming there are no residual hemodynamic defects. The institution of support after cardiovascular collapse has occurred, unfortunately, remains a signi®cant factor for poor outcome. Early initiation of mechanical circulatory support should be considered when signs of hemodynamic instability are developing. Utilizing the same circuit during surgery or having a circuit primed and ready in case it is needed in the intensive care unit, are some of the techniques that allow for the prompt utilization of this therapy. Unfortunately, in our series of patients, although this plan has minimized the time to cannulation in an emergency situation, the survival for post-arrest support remains poor.
Summary
We believe that extracorporeal support provides a valid treatment option in the management of patients with cardiopulmonary dysfunction after stage I Norwood palliation, especially if initiated early. The results of our experience demonstrate that the use of extracorporeal support can rescue some patients and provide an additional increase in the survival rate after surgery for this complex form of congenital heart disease. New modi®cations of extracorporeal support in the subgroup of patients with single ventricle physiology are being explored. Hopefully, this progress will result in improved outcomes for some patients who otherwise would have been lost.
Limitations
The retrospective nature of this study and the small number of patients are important factors that need to be considered, due to the fact that statistical power is lacking in many of the comparisons made. Also the lack of a randomized patient allocation process to the strategy described and the lack of a control group make the analysis dif®cult and susceptible to error. Although the extracorporeal support provided was quite uniform, the lack of a consistent protocol detailing the selection and management of these patients make the data interpretation more dif®cult.
